Robert Kramer Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Kramer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Robert Kramer for February 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Option Exercise | A | 93.49 | 59,898 | 5,599,864 | 59,898 | |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 97.15 | 860 | 83,549 | 163,147 | 164 K to 163.1 K (-0.52 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 97.15 | 1,716 | 166,709 | 164,007 | 165.7 K to 164 K (-1.04 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 93.49 | 2,425 | 226,713 | 165,723 | 168.1 K to 165.7 K (-1.44 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 14,975 | 0 | 168,148 | 153.2 K to 168.1 K (+9.78 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 14,975 | 0 | 153,173 | 138.2 K to 153.2 K (+10.84 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 123.45 | 423 | 52,219 | 138,198 | 138.6 K to 138.2 K (-0.31 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 323 | 0 | 138,621 | 138.3 K to 138.6 K (+0.23 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 123.45 | 3,870 | 477,752 | 138,298 | 142.2 K to 138.3 K (-2.72 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 2,958 | 0 | 142,168 | 139.2 K to 142.2 K (+2.12 %) |
Feb 09 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Option Exercise | M | 30.63 | 13,000 | 398,190 | 19,638 | |
Feb 09 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Option Exercise | M | 30.86 | 32,397 | 999,771 | 0 | |
Feb 09 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Sell | S | 120.03 | 13,000 | 1,560,390 | 139,210 | 152.2 K to 139.2 K (-8.54 %) |
Feb 09 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Buy | M | 30.63 | 13,000 | 398,190 | 152,210 | 139.2 K to 152.2 K (+9.34 %) |
Feb 09 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Sell | S | 120.03 | 32,397 | 3,888,612 | 139,210 | 171.6 K to 139.2 K (-18.88 %) |
Feb 09 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Buy | M | 30.86 | 32,397 | 999,771 | 171,607 | 139.2 K to 171.6 K (+23.27 %) |